Literature DB >> 15083485

Parametric modelling of cost data in medical studies.

R M Nixon1, S G Thompson.   

Abstract

The cost of medical resources used is often recorded for each patient in clinical studies in order to inform decision-making. Although cost data are generally skewed to the right, interest is in making inferences about the population mean cost. Common methods for non-normal data, such as data transformation, assuming asymptotic normality of the sample mean or non-parametric bootstrapping, are not ideal. This paper describes possible parametric models for analysing cost data. Four example data sets are considered, which have different sample sizes and degrees of skewness. Normal, gamma, log-normal, and log-logistic distributions are fitted, together with three-parameter versions of the latter three distributions. Maximum likelihood estimates of the population mean are found; confidence intervals are derived by a parametric BC(a) bootstrap and checked by MCMC methods. Differences between model fits and inferences are explored.Skewed parametric distributions fit cost data better than the normal distribution, and should in principle be preferred for estimating the population mean cost. However for some data sets, we find that models that fit badly can give similar inferences to those that fit well. Conversely, particularly when sample sizes are not large, different parametric models that fit the data equally well can lead to substantially different inferences. We conclude that inferences are sensitive to choice of statistical model, which itself can remain uncertain unless there is enough data to model the tail of the distribution accurately. Investigating the sensitivity of conclusions to choice of model should thus be an essential component of analysing cost data in practice. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15083485     DOI: 10.1002/sim.1744

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  A nonparametric statistical method that improves physician cost of care analysis.

Authors:  Brent A Metfessel; Robert A Greene
Journal:  Health Serv Res       Date:  2012-04-23       Impact factor: 3.402

Review 2.  Sample size determination for cost-effectiveness trials.

Authors:  Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

3.  Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.

Authors:  Theodoros Mantopoulos; Paul M Mitchell; Nicky J Welton; Richard McManus; Lazaros Andronis
Journal:  Eur J Health Econ       Date:  2015-10-07

Review 4.  Economic evaluations: a new avenue of outcome assessment in spinal disorders.

Authors:  Nicole van der Roer; Norbert Boos; Maurits W van Tulder
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

5.  Types of Services and Costs of Programs for Preschoolers with Autism Spectrum Disorder Across Sectors: A Comparison of Two Canadian Provinces.

Authors:  Kate Tsiplova; Wendy J Ungar; Helen E Flanagan; Jeffrey den Otter; Charlotte Waddell; Patricia Murray; Barbara D'Entremont; Natalie Léger; Nancy Garon; Susan Bryson; Isabel M Smith
Journal:  J Autism Dev Disord       Date:  2019-06

6.  An application of longitudinal analysis with skewed outcomes.

Authors:  Andres Azuero; Maria Pisu; Patrick McNees; Jeffrey Burkhardt; Rachel Benz; Karen Meneses
Journal:  Nurs Res       Date:  2010 Jul-Aug       Impact factor: 2.381

7.  Changes in Pediatric Heart Transplant Hospitalization Costs Over Time.

Authors:  Justin Godown; Cary Thurm; Matt Hall; Jonathan H Soslow; Brian Feingold; Bret A Mettler; Andrew H Smith; David W Bearl; Debra A Dodd
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

8.  Mechanical circulatory support costs in children bridged to heart transplantation - analysis of a linked database.

Authors:  Justin Godown; Andrew H Smith; Cary Thurm; Matt Hall; Debra A Dodd; Jonathan H Soslow; Bret A Mettler; David W Bearl; Brian Feingold
Journal:  Am Heart J       Date:  2018-04-06       Impact factor: 4.749

9.  Bayesian modelling of healthcare resource use in multinational randomized clinical trials.

Authors:  Aline Gauthier; Andrea Manca; Susan Anton
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Rehospitalization during the first year of life by insurance status.

Authors:  Nicholas K Schiltz; Beth Finkelstein Rosenthal; Moira A Crowley; Siran M Koroukian; Ann Nevar; Sharon B Meropol; Leona Cuttler
Journal:  Clin Pediatr (Phila)       Date:  2014-06-04       Impact factor: 1.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.